Drug Profile


Alternative Names: AHR 11190; AHR 11190B; MD 780209

Latest Information Update: 22 Jan 1997

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Delalande
  • Developer AH Robins; Delalande
  • Class Antiemetics; Benzamides; Drug withdrawal therapies
  • Mechanism of Action Serotonin 3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Cognition disorders; Major depressive disorder; Nausea and vomiting; Psychotic disorders

Most Recent Events

  • 22 Jan 1997 Discontinued-Unspecified phase in Depression in USA (PO)
  • 22 Jan 1997 Discontinued-Unspecified phase in Emesis in USA (PO)
  • 25 Jun 1996 Discontinued-Unspecified phase in Cognition disorders in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top